Transcriptomics

Dataset Information

Loss of the Inhibitory Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma


ABSTRACT: Mechanisms of immune regulation may control proliferation of aberrant plasma cells (PCs) in patients with the asymptomatic monoclonal gammopathy of undetermined significance (MGUS) preventing progression to active multiple myeloma (MM). We investigated the role of CD85j (LILRB1), an inhibitory immune checkpoint for B cell function, in MM pathogenesis. We used microarrays to gain insight into the molecular mechanisms underlying CD85j functions in myeloma cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE89793 | GEO | 2016/11/14

SECONDARY ACCESSION(S): PRJNA353312

REPOSITORIES: GEO